Aspire Biopharma Holdings (ASBP) Current Taxes (2022 - 2023)
Aspire Biopharma Holdings' (ASBP) quarterly Current Taxes came in at $152689.0 in Q1 2023, up 367.1% year-on-year from $32689.0 in Q1 2022, and up 24.45% on a QoQ basis from $122689.0 in Q4 2022.
Aspire Biopharma Holdings (ASBP) Current Taxes (2022 - 2023) Analysis & Trends
Aspire Biopharma Holdings (ASBP) has 2 years of Current Taxes data on file, last reported at $152689.0 in Q1 2023.
- On a quarterly basis, Current Taxes rose 367.1% year-over-year to $152689.0 in Q1 2023; TTM through Mar 2023 was $152689.0, a 367.1% increase from a year earlier, with the FY2022 full-year figure at $122689.0, changed N/A from the prior year.
- Current Taxes for Q1 2023 stood at $152689.0, up from $122689.0 in the prior quarter.
- Over the last five years, Current Taxes for ASBP reached as high as $152689.0 in Q1 2023 and fell as low as $32689.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | - |
| 2 | Nanobiotix | 1,933.35 Bn | 1,933.29 Bn | - | - |
| 3 | Akari Therapeutics | 1,063.56 Bn | 1,063.56 Bn | - | - |
| 4 | BeOne Medicines | 468.54 Bn | 463.75 Bn | 1.35 Bn | 63.52 Mn |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.20 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 63.57 Bn | 63.57 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | 49.00 Mn |
| 9 | Alnylam Pharmaceuticals | 37.75 Bn | 34.74 Bn | 959.66 Mn | - |
| 10 | Aspire Biopharma Holdings | 1.10 Mn | -722,113.72 | 5,750.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 152,689.00 |
| Dec 31, 2022 | 122,689.00 |
| Sep 30, 2022 | 92,689.00 |
| Jun 30, 2022 | 62,689.00 |
| Mar 31, 2022 | 32,689.00 |